M. D. Anderson Ranked No. 1 Nationwide in Cancer Care By U.S. News & World Report's "America's Best Hospitals"
M. D. Anderson News Release 07/13/07
U.S.News & World Report's "America's Best Hospitals" survey has ranked The University of Texas M. D. Anderson Cancer Center as the top hospital in the nation for cancer care. This is the fifth time in eight years that M. D. Anderson has achieved the highest ranking.
In addition to its top position in cancer, M. D. Anderson is ranked high among other hospitals in three specialties: ear, nose and throat (7), urology (7) and gynecology (8). According to U.S.News & World Report, only 173 hospitals scored high enough this year to rank in a single specialty out of 5,462 evaluated U.S. medical centers.
"To be named the best cancer hospital in the nation is truly an honor," says M. D. Anderson President John Mendelsohn, M.D. "Our employees, faculty and volunteers take great pride in this distinction. It recognizes M. D. Anderson's commitment to providing our patients with the very best in clinical care and innovative treatments."
M. D. Anderson has ranked as one of the top two hospitals in cancer care for 18 years, since the magazine began its annual survey in 1990. Prior to this year, M. D. Anderson ranked No. 1 in 2004, 2003, 2002, 2000 and 1992.
Rankings are based upon a survey of board-certified physicians around the country, patient survival data and a mix of care-related factors such as nurse-to-patient ratio, technologies available and services for patients and the community.
With more than 16,000 faculty and staff and 1,600 volunteers working in more than 25 buildings around Houston and in Central Texas, M. D. Anderson is one of the largest cancer centers in the world.
Size alone is not the reason M. D. Anderson ranks No. 1 in a survey that identifies centers that take on and excel at tough procedures and conditions.
Over the past year, M. D. Anderson has:
- Served 79,000 patients.
- Enrolled 11,000 patients in clinical trials, the largest such program in the nation.
- Invested $409 million on cancer research, a 95% increase from 2001.
- Introduced leading-edge technologies to cancer patients such as proton therapy, robotic surgery and BrainSUITE .
- Broken ground on the Center for Advanced Biomedical Imaging Research, a facility dedicated to developing novel agents and imaging technologies that detect cancer and other illnesses at their earliest stages.
- Been recognized by The Scientist magazine's survey as the No. 1 workplace in the nation for postdoctoral fellows.
"We believe the significant advances and research discoveries made here over the last five years have resulted in even better cancer care and have brought services and technologies to patients that haven't been available before," says Mendelsohn. "We will continue to enhance the care of our patients not just during their cancer treatment, but throughout their continuum of care - from prevention to survivorship."